Vancomycin sensitivity of methicillin resistant Staphylococcus aureus (MRSA) isolates collected from clinical specimens of Tabriz Imam Reza and Sina hospitals by E-test method, agar screening plate and PCR
- سال انتشار: 1395
- محل انتشار: فصلنامه میکروب شناسی پزشکی ایران، دوره: 10، شماره: 1
- کد COI اختصاصی: JR_IJMM-10-1_008
- زبان مقاله: انگلیسی
- تعداد مشاهده: 72
نویسندگان
International Branch of Aras Tabriz University of Medical Sciences, Tabriz, Iran
School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Tabriz University of Medical Sciences, Tabriz, Iran
Tabriz University of Medical Sciences, Tabriz, Iran
School of Medicine,Tabriz University of Medical Sciences,Tabriz,Iran
School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
چکیده
Background and Aim: Vancomycin is one of the last drugs used by human for treatment of infections caused by Methicillin resistant Staphylococcus aureus (MRSA) isolates. Since Staphylococcus aureus with heterogeneous, intermediate and complete resistance to vancomycin are in relation to high mortality rate and are increasing in the world, so investigating the incidence of these isolates is necessary. Materials and Methods: By using several phenotypic tests such as Gram stain, catalase, coagulase, DNase and mannitol fermentations and by screening resistance to methicillin, ۱۰۰ MRSA isolates were identified. For identifying resistance to vancomycin, phenotypic tests with the disc diffusion method, determining MIC by E-test method and screening test in BHIA (Brain Heart Infusion Agar) containing vancomycin and molecular PCR test were carried out in order to identify femB, mecA and vanA genes. Results: Resistance to methicillin was ۵۹%. Ranges of vancomycin MICs were between ۰.۷۵ µg/ml to ۴ µg/ml. By E-test method ۹۲% of isolates were sensitive and ۸% showed heterogeneous resistance to vancomycin. However, screening tests in BHIA, containing ۳ μg/ml and ۴ μg/ml vancomycin, detected ۱۸% heterogeneous resistance and ۴% intermediate resistance to vancomycin, respectively. In screening tests using BHIA, with ۶ μg/ml vancomycin no isolate was able to grow. Although all of the isolates contained femB and mecA genes, but none of them contained vanA gene. Conclusion: E-test alone was not able to identify all S.aureus isolates of heterogeneous resistance and intermediate resistance to vancomycin. As a result, the screening tests also should be used along with MIC tests.کلیدواژه ها
Methicillin- resistant Staphylococcus aureus, Vancomycin, E-test, Screening test, PCR, استافیلوکوکوس اورئوس مقاوم به متی سیلین, وانکومایسین, E-test, آزمون غربالی, PCRاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.